1. The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer’s Biomarker Results to Research Participants

   • C. M. Erickson
   • N. A. Chin
   • Lindsay R. Clark

   Brief Communication 12 July 2023 Pages: 1 - 6

2. Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population

   • Ying Liu
   • H. Jun
   • S. Mattke

   Original Research Open access 24 October 2023 Pages: 7 - 12

   

3. Association of Multi-Domain Factors with Cognition in the UK Biobank Study

   • W. Y. Tan
   • C. A. Hargreaves
   • Saima Hilal

   Original Research 08 January 2024 Pages: 13 - 21

   

4. How Modifiable Are Modifiable Dementia Risk Factors? A Framework for Considering the Modifiability of Dementia Risk Factors

   • Lisa Bransby
   • E. Rosenich
   • Y. Y. Lim

   Review Open access 04 October 2023 Pages: 22 - 37

   

5. Consistency between Treatment Effects on Clinical and Brain Atrophy Outcomes in Alzheimer’s Disease Trials

   • M. ten Kate
   • F. Barkhof
   • Adam J. Schwarz

   Original Research Open access 13 July 2023 Pages: 38 - 47

   

6. Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study

   • M. Ruthirakuhan
   • M. Wood Alexander
   • J. S. Rabin

   Original Research 29 August 2023 Pages: 48 - 55

7. Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force

   • Maria Soto
   • P. Rosenberg
   • EU/US CTAD Task force

   CTAD Task Force Paper 03 October 2023 Pages: 56 - 64

8. Phase 1/2a Intravenous and Subcutaneous Oligomer-Specific Antibody KHK6640 in Mild to Moderate Alzheimer’s Disease

   • Marc Cantillon
   • N. Andreasen
   • N. Prins

   Original Research 08 January 2024 Pages: 65 - 70

   

9. Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment

   • Jeffrey N. Motter
   • S. N. Rushia
   • D. P. Devanand

   Original Research 26 May 2023 Pages: 71 - 78

   

10. Digital Clock Drawing as an Alzheimer’s Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults

    • Louisa I. Thompson
    • M. Cummings
    • C. Liu

    Original Research Open access 28 April 2023 Pages: 79 - 87

11. Lifestyle and Socioeconomic Transition and Health Consequences of Alzheimer’s Disease and Other Dementias in Global, from 1990 to 2019

    • Y. Cui
    • W. Yang
    • Yan Yan

    Original Research 26 May 2023 Pages: 88 - 96

    

12. Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality

    • Krista L. Lanctôt
    • J. Hviid Hahn-Pedersen
    • J. Cummings

    Original Research Open access 01 June 2023 Pages: 97 - 107

    

13. Modifiable Risk Factors for Accelerated Decline in Processing Speed: Results from Three Dutch Population Cohorts

    • E. Jaarsma
    • A. Nooyens
    • M. Huisman

    Original Research Open access 04 June 2023 Pages: 108 - 116

    

14. Relationships of Hypnotics with Incident Dementia and Alzheimer’s Disease: A Longitudinal Study and Meta-Analysis

    • J.-H. Hou
    • S.-L. Sun
    • Wei Xu

    Original Research 13 June 2023 Pages: 117 - 129

    

15. Association of Balance Impairment with Risk of Incident Dementia among Older Adults

    • H. J. Kim
    • S. Jeong
    • Jee Young Suh

    Original Research 13 June 2023 Pages: 130 - 137

    

16. High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer’s Disease Via a Specific Tau Phosphorylation Pattern

    • Y. Ito
    • Shuko Takeda
    • Ryuichi Morishita

    Original Research 22 June 2023 Pages: 138 - 148

    

17. Computerized Cognitive Training in Mild Cognitive Impairment: Findings in African Americans and Caucasians

    • Adaora Nwosu
    • M. Qian
    • P. M. Doraiswamy

    Original Research Open access 13 June 2023 Pages: 149 - 154

    

18. Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers

    • Soeren Mattke
    • A. Gustavsson
    • L. Jönsson

    Original Research Open access 15 September 2023 Pages: 155 - 161

    

19. Cognitive Performance and Incident Alzheimer’s Dementia in Men Versus Women

    • Ioannis Liampas
    • V. Siokas
    • E. Dardiotis

    Original Research Open access 13 July 2023 Pages: 162 - 170

    

20. Global Energy Metabolism Deficit in Alzheimer Disease Brain

    • Viharkumar Patel
    • J. Mill
    • T. Raife

    Original Research Open access 04 August 2023 Pages: 171 - 178

    

21. Projected Savings to Canadian Provincial Budgets from Reduced Long-Term Care Home Utilization Due to a Disease-Modifying Alzheimer’s Treatment

    • H. Jun
    • Z. Shi
    • Soeren Mattke

    Original Research Open access 16 August 2023 Pages: 179 - 184

    

22. Data-Driven Thresholding Statistically Biases ATN Profiling across Cohort Datasets

    • Y. Salimi
    • D. Domingo-Fernández
    • the European Prevention of Alzheimer’s Disease (EPAD) Consortium

    Original Research Open access 06 September 2023 Pages: 185 - 195

    

23. Alzheimer’s Disease and Aging Association: Identification and Validation of Related Genes

    • T. Liu
    • K. Hou
    • Jianshe Wei

    Original Research 05 September 2023 Pages: 196 - 213

    

24. China Alzheimer’s Disease and Neurodegenerative Disorder Research (CANDOR) -A Prospective Cohort Study for Alzheimer’s Disease and Vascular Cognitive Impairment

    • S. Li
    • H. Dong
    • Jiong Shi

    Original Research 29 August 2023 Pages: 214 - 221

25. The Therapeutic Effects of Noninvasive Brain Stimulation Combined with Cognitive Training in Elders with Alzheimer’s Disease or Amnesic Mild Cognitive Impairment

    • J.-Y. Wang
    • J.-Y. Qin
    • Fengxia Yan

    Original Research 08 January 2024 Pages: 222 - 229

    

26. Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults

    • A. Sadlon
    • P. Takousis
    • Alzheimer’s Disease Neuroimaging Initiative

    Original Research Open access 06 September 2023 Pages: 230 - 240

    

27. Are Population-Level Approaches to Dementia Risk Reduction Under-Researched? A Rapid Review of the Dementia Prevention Literature

    • Sebastian Walsh
    • L. Wallace
    • C. Brayne

    Review Open access 15 May 2023 Pages: 241 - 248

    

28. Oral Health as a Risk Factor for Alzheimer Disease

    • S. M. Pruntel
    • B. C. van Munster
    • Anita Visser

    Review Open access 28 June 2023 Pages: 249 - 258

    

29. First Experiences with Amyloid-Related Imaging Abnormalities — Yet without Imaging that Can Rule Out Cerebral Injury or Monitor Efficacy of Recommended Management

    • Poul F. Høilund-Carlsen
    • G. Perry
    • J. R. Barrio

    Letter to the Editor 08 January 2024 Pages: 259 - 260

30. Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment

    • Matthew D. Howe
    • M. C. Riddle
    • S. P. Salloway

    Reply to the Letter to the Editor 08 January 2024 Pages: 261 - 262

31. Erratum to: Digital Clock Drawing as an Alzheimer’s Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults

    • Louisa I. Thompson
    • M. Cummings
    • C. Liu

    Erratum Open access 28 July 2023 Pages: 263 - 263

32. Erratum to: Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer’s Disease Suggest Disease Modification Potential

    • Susan Abushakra
    • A. Porsteinsson
    • M. Tolar

    Erratum 12 January 2024 Pages: 264 - 264